Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders
- PMID: 31061208
- PMCID: PMC6537133
- DOI: 10.1212/WNL.0000000000007466
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders
Abstract
Objective: To make recommendations on the assessment and management of tics in people with Tourette syndrome and chronic tic disorders.
Methods: A multidisciplinary panel consisting of 9 physicians, 2 psychologists, and 2 patient representatives developed practice recommendations, integrating findings from a systematic review and following an Institute of Medicine-compliant process to ensure transparency and patient engagement. Recommendations were supported by structured rationales, integrating evidence from the systematic review, related evidence, principles of care, and inferences from evidence.
Results: Forty-six recommendations were made regarding the assessment and management of tics in individuals with Tourette syndrome and chronic tic disorders. These include counseling recommendations on the natural history of tic disorders, psychoeducation for teachers and peers, assessment for comorbid disorders, and periodic reassessment of the need for ongoing therapy. Treatment options should be individualized, and the choice should be the result of a collaborative decision among patient, caregiver, and clinician, during which the benefits and harms of individual treatments as well as the presence of comorbid disorders are considered. Treatment options include watchful waiting, the Comprehensive Behavioral Intervention for Tics, and medication; recommendations are provided on how to offer and monitor these therapies. Recommendations on the assessment for and use of deep brain stimulation in adults with severe, treatment-refractory tics are provided as well as suggestions for future research.
© 2019 American Academy of Neurology.
Similar articles
-
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.Neurology. 2019 May 7;92(19):907-915. doi: 10.1212/WNL.0000000000007467. Neurology. 2019. PMID: 31061209 Free PMC article.
-
Self-esteem in adults with Tourette syndrome and chronic tic disorders: The roles of tic severity, treatment, and comorbidity.Compr Psychiatry. 2018 Jul;84:95-100. doi: 10.1016/j.comppsych.2018.04.008. Epub 2018 Apr 23. Compr Psychiatry. 2018. PMID: 29729555 Free PMC article. Clinical Trial.
-
Exploring Social Support in an Online Support Community for Tourette Syndrome and Tic Disorders: Analysis of Postings.J Med Internet Res. 2022 Oct 4;24(10):e34403. doi: 10.2196/34403. J Med Internet Res. 2022. PMID: 36194454 Free PMC article.
-
Description, Implementation, and Efficacy of the Comprehensive Behavioral Intervention for Tics as First-Line Treatment for Tourette and Other Tic Disorders.J Child Adolesc Psychopharmacol. 2025 Apr;35(3):126-134. doi: 10.1089/cap.2024.0023. Epub 2024 Sep 23. J Child Adolesc Psychopharmacol. 2025. PMID: 39311713 Review.
-
Reward enhances tic suppression in children within months of tic disorder onset.Dev Cogn Neurosci. 2015 Feb;11:65-74. doi: 10.1016/j.dcn.2014.08.005. Epub 2014 Aug 28. Dev Cogn Neurosci. 2015. PMID: 25220075 Free PMC article. Clinical Trial.
Cited by
-
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis.Eur J Clin Pharmacol. 2024 Oct;80(10):1483-1493. doi: 10.1007/s00228-024-03710-9. Epub 2024 Jul 10. Eur J Clin Pharmacol. 2024. PMID: 38985199 Free PMC article.
-
Prevalence of nail biting and its chronological relationship with tics in child and adolescent outpatients with Tourette syndrome: a single-centre, retrospective observational study.BMJ Open. 2022 Sep 15;12(9):e063874. doi: 10.1136/bmjopen-2022-063874. BMJ Open. 2022. PMID: 36109039 Free PMC article.
-
Childhood Predictors of Long-Term Tic Severity and Tic Impairment in Tourette's Disorder.Behav Ther. 2022 Nov;53(6):1250-1264. doi: 10.1016/j.beth.2022.07.002. Epub 2022 Jul 16. Behav Ther. 2022. PMID: 36229120 Free PMC article. Clinical Trial.
-
Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota.Front Pharmacol. 2022 Mar 22;13:819872. doi: 10.3389/fphar.2022.819872. eCollection 2022. Front Pharmacol. 2022. PMID: 35392572 Free PMC article.
-
Mental Health Surveillance Among Children - United States, 2013-2019.MMWR Suppl. 2022 Feb 25;71(2):1-42. doi: 10.15585/mmwr.su7102a1. MMWR Suppl. 2022. PMID: 35202359 Free PMC article.
References
-
- Groth C, Mol Debes N, Rask CU, Lange T, Skov L. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry 2017;56:304–312. - PubMed
-
- Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol 2012;47:77–90. - PubMed
-
- Nussey C, Pistrang N, Murphy T. How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder. Child Care Health Dev 2013;39:617–627. - PubMed
-
- Kurlan R, Como PG, Miller B, et al. . The behavioural spectrum of tic disorders: a community based study. Neurology 2002;59:414–420. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical